77 related articles for article (PubMed ID: 23474438)
1. Steroid receptor coactivator-1: a versatile regulator and promising therapeutic target for breast cancer.
Zhang Y; Duan C; Bian C; Xiong Y; Zhang J
J Steroid Biochem Mol Biol; 2013 Nov; 138():17-23. PubMed ID: 23474438
[TBL] [Abstract][Full Text] [Related]
2. Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1.
McBryan J; Theissen SM; Byrne C; Hughes E; Cocchiglia S; Sande S; O'Hara J; Tibbitts P; Hill AD; Young LS
Cancer Res; 2012 Jan; 72(2):548-59. PubMed ID: 22108824
[TBL] [Abstract][Full Text] [Related]
3. Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer [corrected].
McIlroy M; McCartan D; Early S; O Gaora P; Pennington S; Hill AD; Young LS
Cancer Res; 2010 Feb; 70(4):1585-94. PubMed ID: 20145129
[TBL] [Abstract][Full Text] [Related]
4. Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1.
Fleming FJ; Myers E; Kelly G; Crotty TB; McDermott EW; O'Higgins NJ; Hill AD; Young LS
J Clin Pathol; 2004 Oct; 57(10):1069-74. PubMed ID: 15452162
[TBL] [Abstract][Full Text] [Related]
5. The function of steroid receptor coactivator-1 in normal tissues and cancer.
Walsh CA; Qin L; Tien JC; Young LS; Xu J
Int J Biol Sci; 2012; 8(4):470-85. PubMed ID: 22419892
[TBL] [Abstract][Full Text] [Related]
6. Global gene repression by the steroid receptor coactivator SRC-1 promotes oncogenesis.
Walsh CA; Bolger JC; Byrne C; Cocchiglia S; Hao Y; Fagan A; Qin L; Cahalin A; McCartan D; McIlroy M; O'Gaora P; Xu J; Hill AD; Young LS
Cancer Res; 2014 May; 74(9):2533-44. PubMed ID: 24648347
[TBL] [Abstract][Full Text] [Related]
7. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
8. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
9. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.
Kishimoto H; Wang Z; Bhat-Nakshatri P; Chang D; Clarke R; Nakshatri H
Carcinogenesis; 2005 Oct; 26(10):1706-15. PubMed ID: 15917309
[TBL] [Abstract][Full Text] [Related]
10. Endocrine therapy and other targeted therapies for metastatic breast cancer.
Hussain SA; Palmer DH; Moon S; Rea DW
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1179-95. PubMed ID: 15606341
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.
Mc Ilroy M; Fleming FJ; Buggy Y; Hill AD; Young LS
Endocr Relat Cancer; 2006 Dec; 13(4):1135-45. PubMed ID: 17158759
[TBL] [Abstract][Full Text] [Related]
12. Steroid hormone receptor signaling in tumorigenesis.
Singh RR; Kumar R
J Cell Biochem; 2005 Oct; 96(3):490-505. PubMed ID: 16092128
[TBL] [Abstract][Full Text] [Related]
13. Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.
Haugan Moi LL; Hauglid Flågeng M; Gandini S; Guerrieri-Gonzaga A; Bonanni B; Lazzeroni M; Gjerde J; Lien EA; DeCensi A; Mellgren G
Clin Cancer Res; 2010 Apr; 16(7):2176-86. PubMed ID: 20332317
[TBL] [Abstract][Full Text] [Related]
14. Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways.
Chen PH; Peng CY; Pai HC; Teng CM; Chen CC; Yang CR
J Nutr Biochem; 2011 Aug; 22(8):732-40. PubMed ID: 21062671
[TBL] [Abstract][Full Text] [Related]
15. A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo.
Jallal H; Valentino ML; Chen G; Boschelli F; Ali S; Rabbani SA
Cancer Res; 2007 Feb; 67(4):1580-8. PubMed ID: 17308097
[TBL] [Abstract][Full Text] [Related]
16. [Expression of stromal cell-derived factor-1 in endometriosis by steroid receptor coactivators on steroid hormone].
Shi X; Xu W; Sun Y; Dai H; Wang X
Zhonghua Fu Chan Ke Za Zhi; 2014 Feb; 49(2):114-9. PubMed ID: 24739643
[TBL] [Abstract][Full Text] [Related]
17. Identification of verrucarin a as a potent and selective steroid receptor coactivator-3 small molecule inhibitor.
Yan F; Yu Y; Chow DC; Palzkill T; Madoux F; Hodder P; Chase P; Griffin PR; O'Malley BW; Lonard DM
PLoS One; 2014; 9(4):e95243. PubMed ID: 24743578
[TBL] [Abstract][Full Text] [Related]
18. Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerations.
Gururaj AE; Rayala SK; Vadlamudi RK; Kumar R
Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1001s-1007s. PubMed ID: 16467116
[TBL] [Abstract][Full Text] [Related]
19. SRC-3/AIB1: transcriptional coactivator in oncogenesis.
Yan J; Tsai SY; Tsai MJ
Acta Pharmacol Sin; 2006 Apr; 27(4):387-94. PubMed ID: 16539836
[TBL] [Abstract][Full Text] [Related]
20. Regulation of CXCR4 gene expression in breast cancer cells under diverse stress conditions.
Andreou K; Rajendran R; Krstic-Demonacos M; Demonacos C
Int J Oncol; 2012 Dec; 41(6):2253-9. PubMed ID: 23023398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
